Baricitinib in Idiopathic Granulomatous Mastitis

NCT05852171 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Mastitis Chronic
Idiopathic Granulomatous Mastitis

Interventions

DRUG: Baricitinib

Sponsor

First Affiliated Hospital of Zhejiang University